AAREY DRUGS & PHARMACEUTICALS
Back to Income Statement
|
AAREY DRUGS & PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹398 Cr | ₹419 Cr | ₹493 Cr | ₹34,841,641 Cr | ₹300 Cr |
What is the latest Revenue of AAREY DRUGS & PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹398 Cr |
| Mar2024 | ₹419 Cr |
| Mar2023 | ₹493 Cr |
| Mar2022 | ₹34,841,641 Cr |
| Mar2021 | ₹300 Cr |
How is Revenue of AAREY DRUGS & PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹398 Cr | -5.09 | |
| Mar2024 | ₹419 Cr | -14.98 | |
| Mar2023 | ₹493 Cr | -100.00 | |
| Mar2022 | ₹34,841,641 Cr | 11,610,336.07 | |
| Mar2021 | ₹300 Cr | - | |
Compare Revenue of peers of AAREY DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AAREY DRUGS & PHARMACEUTICALS | ₹251.2 Cr | 1.6% | 12.4% | 68.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,121.0 Cr | 3.2% | 12.5% | 10.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,396.0 Cr | 2.9% | 8.5% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,730.0 Cr | 0.3% | 5.7% | 36.3% | Stock Analytics | |
| CIPLA | ₹115,241.0 Cr | 10.4% | 15.9% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,126.0 Cr | 4.8% | 9% | 10.8% | Stock Analytics | |
AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AAREY DRUGS & PHARMACEUTICALS | 1.6% |
12.4% |
68.2% |
| SENSEX | -0.9% |
-3.6% |
-8.6% |
You may also like the below Video Courses